Brief: Quotient Reports Results From Independent Sars-Cov-2 Antibody Detection Study Conducted In Spain
20/07/2020 11:24
July 20 (Reuters) - Quotient Ltd QTNT.O :
* QUOTIENT LIMITED REPORTS IMPRESSIVE RESULTS FROM AN
INDEPENDENT
SARS-COV-2 ANTIBODY DETECTION STUDY CONDUCTED IN SPAIN
* QUOTIENT LTD - INDEPENDENT STUDY FOUND MOSAIQ COVID-19
ANTIBODY
MICROARRAY DEMONSTRATED 100% SENSITIVITY AND 99.8% SPECIFICITY
Source text for Eikon: ID:nGNXc2H18Y
Further company coverage: QTNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quotient
See all newsBrief: Quotient Ltd Enters Into Amended And Restated Transaction Support Agreement
U.S. STOCKS ON THE MOVE-Tesla, Exxon Mobil, Chevron
Quotient down on plans to delist from Nasdaq
Brief: Quotient Limited Announces Intent To Voluntary Delist From The Nasdaq Global Market
U.S. STOCKS ON THE MOVE-Organon, Veracyte, InfuSystem